Dr. Louis F. Centofanti, Chairman and Chief Executive Officer, stated, "We are very excited to unveil this breakthrough technology. There are a number of important benefits to our new process. First, we believe this technology has the potential to alleviate the worldwide shortages of Tc-99m, due to its use of readily-available, natural Molybdenum, rather than highly enriched uranium. Additionally, we believe that this technology can be easily deployed around the world using standard research and commercial reactors, thereby eliminating the need for more special purpose reactors. We expect this process will be much better for the environment since waste generated during the production process is more readily treated and disposed. Until now, there were no viable treatment or disposal options for the waste generated from production of these isotopes. Moreover, our process is far less expensive and does not require the use of government-subsidized, weapons-grade materials. As a result, we expect our process will alleviate major concerns about nuclear proliferation, which have plagued the industry."Dr. Centofanti continued, "In addition to our proprietary processes, we believe we are well positioned to commercialize this technology due to our unique facilities and permits. Our facilities have been used in the past to produce radioisotopes for medicinal uses and this technology is a natural extension of our capabilities into new markets. Ultimately, we believe these technologies will not only reduce costs, help the environment, and solve proliferation concerns, but more importantly, will benefit the patients that require a steady and reliable supply of these isotopes for life saving medical procedures. We are very proud to be a part of this major undertaking."
Perma-Fix Signs Option Agreement To License Technology For Use In Proprietary Process To Produce Medical Isotopes
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts